JP2025508910A5 - - Google Patents
Info
- Publication number
- JP2025508910A5 JP2025508910A5 JP2024550836A JP2024550836A JP2025508910A5 JP 2025508910 A5 JP2025508910 A5 JP 2025508910A5 JP 2024550836 A JP2024550836 A JP 2024550836A JP 2024550836 A JP2024550836 A JP 2024550836A JP 2025508910 A5 JP2025508910 A5 JP 2025508910A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- nucleic acid
- nucleotide sequence
- viral vector
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263316241P | 2022-03-03 | 2022-03-03 | |
| US63/316,241 | 2022-03-03 | ||
| US202263387223P | 2022-12-13 | 2022-12-13 | |
| US63/387,223 | 2022-12-13 | ||
| PCT/US2023/063676 WO2023168400A2 (en) | 2022-03-03 | 2023-03-03 | Materials and methods for the treatment of eif2b5 mutations and diseases resulting therefrom |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508910A JP2025508910A (ja) | 2025-04-10 |
| JP2025508910A5 true JP2025508910A5 (https=) | 2026-03-09 |
Family
ID=86054103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024550836A Pending JP2025508910A (ja) | 2022-03-03 | 2023-03-03 | Ｅｉｆ２ｂ５の変異及びそれに起因する疾患の治療のための材料及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250186621A1 (https=) |
| EP (1) | EP4486900A2 (https=) |
| JP (1) | JP2025508910A (https=) |
| AU (1) | AU2023227586A1 (https=) |
| CA (1) | CA3253405A1 (https=) |
| WO (1) | WO2023168400A2 (https=) |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| PT728214E (pt) | 1993-11-09 | 2004-11-30 | Ohio Med College | Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado |
| WO1995013365A1 (en) | 1993-11-09 | 1995-05-18 | Targeted Genetics Corporation | Generation of high titers of recombinant aav vectors |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| CA2207927A1 (en) | 1994-12-06 | 1996-06-13 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant aav vectors |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| WO1997008298A1 (en) | 1995-08-30 | 1997-03-06 | Genzyme Corporation | Chromatographic purification of adenovirus and aav |
| US6632670B1 (en) | 1995-09-08 | 2003-10-14 | Genzyme Corporation | AAV vectors for gene therapy |
| US5910434A (en) | 1995-12-15 | 1999-06-08 | Systemix, Inc. | Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| JP2001500497A (ja) | 1996-09-06 | 2001-01-16 | トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 組換えアデノ随伴ウイルスに指図される遺伝子治療の方法 |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| DK1009808T3 (da) | 1997-09-05 | 2013-01-21 | Genzyme Corp | Fremgangsmåder til generering af hjælper-frie præparater af rekombinante aav-vektorer med høj titer |
| US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| US7056502B2 (en) | 2000-04-28 | 2006-06-06 | The Trustees Of The University Of Pennsylvania | Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids |
| WO2002053703A2 (en) | 2001-01-05 | 2002-07-11 | Children's Hospital, Inc. | Aav2 vectors and methods |
| PT1453547T (pt) | 2001-12-17 | 2016-12-28 | Univ Pennsylvania | Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas |
| DE102012007232B4 (de) | 2012-04-07 | 2014-03-13 | Susanne Weller | Verfahren zur Herstellung von rotierenden elektrischen Maschinen |
| JP2015092462A (ja) | 2013-09-30 | 2015-05-14 | Tdk株式会社 | 正極及びそれを用いたリチウムイオン二次電池 |
| WO2015141521A1 (ja) | 2014-03-21 | 2015-09-24 | 株式会社日立国際電気 | 基板処理装置、半導体装置の製造方法及び記録媒体 |
| JP6197169B2 (ja) | 2014-09-29 | 2017-09-20 | 東芝メモリ株式会社 | 半導体装置の製造方法 |
| GB201616565D0 (en) * | 2016-09-29 | 2016-11-16 | Oxford University Innovation Limited | Method |
| US12448629B2 (en) * | 2018-10-05 | 2025-10-21 | University Of Massachusetts | rAAV vectors for the treatment of GM1 and GM2 gangliosidosis |
| CN114107387A (zh) * | 2021-11-05 | 2022-03-01 | 中国科学院精密测量科学与技术创新研究院 | 一种可用于全脑星形胶质细胞活体成像的腺相关病毒及其应用 |
-
2023
- 2023-03-03 AU AU2023227586A patent/AU2023227586A1/en active Pending
- 2023-03-03 CA CA3253405A patent/CA3253405A1/en active Pending
- 2023-03-03 WO PCT/US2023/063676 patent/WO2023168400A2/en not_active Ceased
- 2023-03-03 JP JP2024550836A patent/JP2025508910A/ja active Pending
- 2023-03-03 US US18/837,099 patent/US20250186621A1/en active Pending
- 2023-03-03 EP EP23718574.9A patent/EP4486900A2/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250161485A1 (en) | Aav capsid variants and uses thereof | |
| JP2020533959A5 (https=) | ||
| CN114981444B (zh) | Aav5的分离的修饰的vp1衣壳蛋白 | |
| Xu et al. | Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside | |
| EP3701030A1 (en) | Gene therapies for neurodegenerative disease | |
| JP2023542614A5 (https=) | ||
| JP2023514242A5 (https=) | ||
| JP2020519629A5 (https=) | ||
| JP2023537980A5 (https=) | ||
| JP2017529395A5 (https=) | ||
| US12534741B2 (en) | Compositions and methods for treatment of neurological disorders | |
| WO2025038430A1 (en) | Aav capsid variants and uses thereof | |
| JP2021534766A5 (https=) | ||
| US20200283800A1 (en) | Gene therapies for neurodegenerative diseases | |
| JP2022545378A5 (https=) | ||
| JP2025508910A5 (https=) | ||
| JP2022526429A5 (https=) | ||
| Chen | Adeno-associated virus vectors for human gene therapy | |
| JP2023542950A5 (https=) | ||
| US20240350663A1 (en) | Isolated modified aav9 capsid protein vp1 | |
| JP2024537167A5 (https=) | ||
| US12480098B1 (en) | Adeno-associated virus variant | |
| KR102874560B1 (ko) | 아데노연관바이러스 변이체 | |
| JP2022552014A5 (https=) | ||
| JP2023536067A5 (https=) |